Corrigendum: Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all

Pedro Nogueira Fontana ^1,2* Vinícius Gomes da Silva ¹ Roseli Corazzini ¹ Natalia Merten Athayde ¹ Ana Marina Dutra Ferreira Da Silva ¹ Igor Brockhausen ¹ Carolina Da Cunha-Correia ² Cláudia F R Sobreira ³ Pedro José Tomaselli ³ Flavio Petean ³ Rodrigo De Oliveira ³ Pablo Feitoza ⁴ Michel Moraes Soane ⁵ Natalia Saraiva ⁵ Rafaela Hidalgo ⁵ Claudia Fideles ⁵ David Feder ¹ Alzira Carvalho ^1*

• ¹ Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil
• ² Faculdade de Ciências Médicas, Universidade de Pernambuco, Recife, Pernambuco, Brazil
• ³ Department of Neurosciences and Behavioral Sciences, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirao Preto, Sao Paulo, Brazil
• ⁴ Faculty of Medicine, Federal University of Amazonas, Manaus, Amazonas, Brazil
• ⁵ EUROInstitute - EUROIMMUN Brasil, São Caetano do Sul, São Paulo, Brazil

Corrigendum: Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not allIncorrect Author NamePlease also check that the initials used in the Author Contributions section or elsewhere in the article are correct.In the published article, an author name was incorrectly written as Pedro Tomaselli. The correct spelling is Pedro José Tomaselli. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.Author Contributions section – incorrect:PF: Data curation, Formal analysis, Validation, Writing – original draft. VS: Data curation, Formal analysis, Writing – review & editing. RC: Resources, Writing – review & editing. NA: Data curation, Investigation, Writing – review & editing. AF: Investigation, Resources, Writing – review & editing. IB: Investigation, Resources, Writing – review & editing. CC: Investigation, Writing – review & editing. CS: Investigation, Writing – review & editing. PT: Investigation, Writing – review & editing. FP: Investigation, Writing – review & editing. RO: Investigation, Writing – review & editing. PF: Investigation, Writing – review & editing. MM: Funding acquisition, Resources, Validation, Writing – review & editing. NS: Resources, Validation, Writing – review & editing. RH: Resources, Validation, Writing – review & editing. CF: Resources, Validation, Writing – review & editing. DF: Investigation, Writing – review & editing. AC: Conceptualization, Funding acquisition, Project administration, Validation, Writing – review & editing.Author Contributions section – correct:PF: Data curation, Formal analysis, Validation, Writing – original draft. VS: Data curation, Formal analysis, Writing – review & editing. RC: Resources, Writing – review & editing. NA: Data curation, Investigation, Writing – review & editing. AF: Investigation, Resources, Writing – review & editing. IB: Investigation, Resources, Writing – review & editing. CC: Investigation, Writing – review & editing. CS: Investigation, Writing – review & editing. PJT: Investigation, Writing – review & editing. FP: Investigation, Writing – review & editing. RO: Investigation, Writing – review & editing. PF: Investigation, Writing – review & editing. MM: Funding acquisition, Resources, Validation, Writing – review & editing. NS: Resources, Validation, Writing – review & editing. RH: Resources, Validation, Writing – review & editing. CF: Resources, Validation, Writing – review & editing. DF: Investigation, Writing – review & editing. AC: Conceptualization, Funding acquisition, Project administration, Validation, Writing – review & editing.